生物活性 | |||
---|---|---|---|
描述 | AMG-47a is a highly potent and orally bioavailable inhibitor of lymphocyte-specific protein tyrosine kinase (Lck), with an exceptionally low IC50 of 0.2 nM. Beyond its primary target, AMG-47a also effectively inhibits several other kinases, including VEGF2, p38α, Jak3, alongside mixed lymphocyte reaction (MLR) and interleukin-2 (IL-2) production, with IC50 values ranging from 1 nM to 72 nM. These properties equip AMG-47a with significant anti-inflammatory capabilities, marking it as a compound of interest for inflammatory disease research and potential therapeutic development[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.87mL 0.37mL 0.19mL |
9.34mL 1.87mL 0.93mL |
18.67mL 3.73mL 1.87mL |
参考文献 |
---|